Gross N J
Medical Service, Hines Veterans Administration Hospital 60141.
Am J Physiol. 1991 Apr;260(4 Pt 1):L311-7. doi: 10.1152/ajplung.1991.260.4.L311.
The accompanying paper [Am. J. Physiol. 260 (Lung Cell. Mol. Physiol. 4): L302-L310, 1991] showed that in the radiation pneumonitis model of adult respiratory distress syndrome (ARDS) there was an excess of the proximate, higher buoyant density subtypes of alveolar surfactant, and a decrease in the light buoyant density form. Because the surfactant subtypes normally evolve from the former to the latter a delay in the alveolar metabolism of surfactant could explain this disproportion. Three possible mechanisms of a delay in surfactant metabolism in radiation pneumonitis were explored using an in vitro model of surfactant subtype metabolism called "cycling". The first was that the surfactant of mice with radiation pneumonitis was intrinsically less capable of conversion to the light subtype. It was found, however, that the proximate forms of surfactant of mice with radiation pneumonitis were as capable of generating light subtype as those of control mice. The second was that there was a deficit in the serine protease activity, called "convertase", that mediates the conversion. But it was found that lungs of mice with radiation pneumonitis released convertase activity to the same extent as control lungs. The third was that an inhibitor of convertase activity was present in the alveoli. It was found that the alveolar lavage fluid of mice with radiation pneumonitis inhibited the conversion of exogenous surfactant by exogenous convertase. Moreover, it contained an 18-fold excess of antiprotease activity. The present data are interpreted as suggesting that an inhibitor in the alveolar space is responsible for the delay in surfactant subtype metabolism in radiation pneumonitis, resulting in the disproportion of surfactant subtypes in radiation pneumonitis.(ABSTRACT TRUNCATED AT 250 WORDS)
随附论文[《美国生理学杂志》260卷(肺细胞与分子生理学4):L302 - L310,1991年]表明,在成人呼吸窘迫综合征(ARDS)的放射性肺炎模型中,肺泡表面活性物质的近端、较高浮力密度亚型过量,而轻浮力密度形式减少。由于表面活性物质亚型通常从前一种向后一种演变,表面活性物质肺泡代谢的延迟可以解释这种不均衡。使用一种称为“循环”的表面活性物质亚型代谢体外模型,探讨了放射性肺炎中表面活性物质代谢延迟的三种可能机制。第一种是患有放射性肺炎的小鼠的表面活性物质本质上转化为轻亚型的能力较低。然而,发现患有放射性肺炎的小鼠的近端形式的表面活性物质与对照小鼠的表面活性物质一样有能力产生轻亚型。第二种是介导转化的丝氨酸蛋白酶活性(称为“转化酶”)存在缺陷。但发现患有放射性肺炎的小鼠的肺释放转化酶活性的程度与对照肺相同。第三种是肺泡中存在转化酶活性的抑制剂。发现患有放射性肺炎的小鼠的肺泡灌洗液抑制外源性转化酶对外源性表面活性物质的转化。此外,它含有过量18倍的抗蛋白酶活性。目前的数据被解释为表明肺泡空间中的一种抑制剂是放射性肺炎中表面活性物质亚型代谢延迟的原因,导致放射性肺炎中表面活性物质亚型的不均衡。(摘要截断于250字)